[Research progress of the mechanisms underlying cadmium-induced carcinogenesis]

C L Xiao1, Y Liu, W Tu

  • 1Department of Occupational and Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Insights

Cadmium exposure can cause cancer through epigenetic changes like DNA methylation and histone modifications. This review explores these and other non-epigenetic pathways involved in cadmium-induced carcinogenesis.

Area of Science:

  • Environmental Toxicology
  • Cancer Research
  • Epigenetics

Background:

  • Cadmium is an indirect genotoxic carcinogen.
  • Epigenetic modifications are increasingly recognized as key factors in carcinogenesis.
  • Understanding cadmium's carcinogenic mechanisms is crucial for public health.

Purpose of the Study:

  • To review the epigenetic mechanisms of cadmium-induced carcinogenesis.
  • To explore non-epigenetic pathways contributing to cadmium's carcinogenicity.
  • To provide a comprehensive overview of cadmium's carcinogenic processes.

Main Methods:

  • Literature review of scientific research on cadmium and cancer.
  • Analysis of studies investigating epigenetic alterations (DNA methylation, histone modifications, microRNA expression).
  • Examination of research on non-epigenetic mechanisms (gene regulation, DNA repair, apoptosis, oxidative stress, autophagy).

Main Results:

  • Epigenetic alterations, including disrupted DNA methylation, histone modifications, and microRNA expression, are linked to cadmium-induced carcinogenesis.
  • Cadmium disrupts gene expression and signaling pathways, represses DNA repair, and suppresses apoptosis.
  • Oxidative stress and autophagy are also implicated in cadmium's carcinogenic effects.

Conclusions:

  • Epigenetic modifications represent a significant mechanism in cadmium-induced carcinogenesis.
  • A combination of epigenetic and non-epigenetic factors contributes to cadmium's carcinogenicity.
  • Further research into these mechanisms can inform preventative strategies and therapeutic interventions.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Structure of Cadherins01:25

Structure of Cadherins

The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
5.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
104
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
943